Core Viewpoint - The financial performance of Kangtong Medical shows a significant decline in revenue and net profit, indicating potential challenges for the company in the near future [2]. Group 1: Financial Performance - As of November 28, 2025, Kangtong Medical reported a revenue of 344 million yuan, a year-on-year decrease of 30.06% [2]. - The company recorded a net profit of -10.21 million yuan, reflecting a year-on-year decrease of 150.92% [2]. - Cumulative cash dividends since the A-share listing amount to 48.9973 million yuan [3]. Group 2: Shareholder and Market Activity - As of December 3, 2025, the number of shareholders for Kangtong Medical is 7,481, a decrease of 5.24% from the previous period [2]. - The average number of circulating shares per shareholder is 8,426, which has increased by 5.53% compared to the last period [2]. - On December 3, 2025, the stock price of Kangtong Medical fell by 0.72%, with a trading volume of 19.146 million yuan [1]. Group 3: Financing and Margin Trading - On December 3, 2025, Kangtong Medical had a financing buy-in of 543,400 yuan, with a net financing buy of -148,120 yuan [1]. - The total financing and margin trading balance for Kangtong Medical is 29.0609 million yuan, with the financing balance accounting for 1.90% of the circulating market value [1]. - The company’s margin trading balance is at a high level, with a margin balance of 2,197 yuan and a margin stock quantity of 100 shares [1]. Group 4: Business Overview - Kangtong Medical, established on January 13, 1998, is located in Chengdu, Sichuan Province, and was listed on July 25, 2023 [1]. - The company's main business involves providing medical institutions with overall solutions centered on medical gas systems and clean operating rooms [1]. - The revenue composition includes: 55.69% from clean medical equipment and systems, 37.30% from medical gas equipment and systems, 4.06% from medical equipment and other product sales, 2.81% from operation and maintenance services, and 0.14% from other sources [1].
港通医疗12月3日获融资买入54.34万元，融资余额2905.87万元